From the authors
From the authors
复制标题
DOI:
10.1183/09031936.05.00082405
复制
发表时间:
2005-10
影响因子:
24.3
通讯作者:
Y. Lacasse;F. Maltais
中科院分区:
文献类型:
--
作者:
Y. Lacasse;F. Maltais
I. Garcia-Talavera's reaction to the results of our trial of ambulatory oxygen (AO) in oxygen-dependent chronic obstructive pulmonary disease (COPD) is of no surprise to us. We realise that our findings, i.e. that as-needed AO provided for a period of 3 months had no effect on quality of life and walked distance 1, are against the stream of current guidelines ( i.e. that active patients receiving long-term oxygen therapy should have both stationary and mobile systems of oxygen delivery) 2 …